From: Epidemiology and patient journey of Rett syndrome in the United States: a real-world evidence study
Characteristics | Overall RTT cohort | Stratification by Age | |
---|---|---|---|
Pediatric (< 18 years of age) | Adult (≥ 18 years of age) | ||
N = 5,940 | N = 3,078 | N = 2,862 | |
Demographicsa | |||
Age at index date, years, mean ± SD [median] | 20.0 ± 14.5 [17.0] | 9.2 ± 4.6 [9.0] | 31.6 ± 12.5 [29.0] |
Pediatric, n (%) | – | ||
0–4 | 612 (10.3) | 612 (19.9) | – |
5–10 | 1,194 (20.1) | 1,194 (38.8) | – |
11–17 | 1,272 (21.4) | 1,272 (41.3) | – |
Adult, n (%) | |||
18–29 | 1,513 (25.5) | – | 1,513 (52.9) |
30–39 | 786 (13.2) | – | 786 (27.5) |
40–49 | 316 (5.3) | – | 316 (11.0) |
≥ 50 | 247 (4.2) | – | 247 (8.6) |
Region, n (%) | |||
South | 2,051 (34.5) | 1,155 (37.5) | 896 (31.3) |
West | 1,373 (23.1) | 716 (23.3) | 657 (23.0) |
Midwest | 1,328 (22.4) | 648 (21.1) | 680 (23.8) |
Northeast | 1,151 (19.4) | 538 (17.5) | 613 (21.4) |
Otherb | 4 (0.1) | 2 (0.1) | 2 (0.1) |
Unknown/Unspecified | 33 (0.6) | 19 (0.6) | 14 (0.5) |
Insurance plan type at index date, n (%) | |||
Unknown/Unspecified Planc | 1,658 (27.9) | 998 (32.4) | 660 (23.1) |
Medicaid | 1,621 (27.3) | 858 (27.9) | 763 (26.7) |
Commercial | 1,101 (18.5) | 675 (21.9) | 426 (14.9) |
Medicare/Medicaid Dual Eligible | 895 (15.1) | 528 (17.2) | 367 (12.8) |
Medicare | 665 (11.2) | 19 (0.6) | 646 (22.6) |
Year of index date, n (%) | |||
2016 | 2,224 (37.4) | 1,203 (39.1) | 1,021 (35.7) |
2017 | 2,095 (35.3) | 1,024 (33.3) | 1,071 (37.4) |
2018 | 1,014 (17.1) | 522 (17.0) | 492 (17.2) |
2019 | 607 (10.2) | 329 (10.7) | 278 (9.7) |
Quan-CCI,d,e mean ± SD [median] | 0.1 ± 0.4 [0.0] | 0.1 ± 0.3 [0.0] | 0.1 ± 0.5 [0.0] |
MECP2 genetic testing, d ,f n (%) | 69 (1.2) | 61 (2.0) | 8 (0.3) |
Time from MECP2 genetic testing date to index date,g days, mean ± SD [median] | 51.5 ± 46.0 [45.0] | 57.2 ± 45.3 [53.0] | 8.1 ± 23.0 [0.0] |
Rendering provider specialty, d, g ,h n (%) | |||
Unknown/missing | 41 (59.4) | 37 (60.7) | 4 (50.0) |
Pediatrician/pediatric specialisti | 16 (23.2) | 14 (23.0) | 2 (25.0) |
Genetics/pathology specialist | 7 (10.1) | 7 (11.5) | 0 (0.0) |
Primary care | 4 (5.8) | 2 (3.3) | 2 (25.0) |
Neurologist | 1 (1.4) | 1 (1.6) | 0 (0.0) |
Differential diagnosis of RTT, d n (%) | |||
Any differential diagnosis | 963 (16.2) | 613 (19.9) | 350 (12.2) |
Autism spectrum disorder | 367 (6.2) | 269 (8.7) | 98 (3.4) |
Cerebral palsy | 413 (7.0) | 171 (5.6) | 242 (8.5) |
Non-specific developmental delay | 321 (5.4) | 284 (9.2) | 37 (1.3) |
Angelman syndrome | 2 (0.0) | 2 (0.1) | 0 (0.0) |
Other childhood disintegrative disorder | 6 (0.1) | 3 (0.1) | 3 (0.1) |
All-cause healthcare resource utilization,j–l PPM, mean ± SD [median] | 3.01 ± 5.92 [0.94] | 3.56 ± 6.34 [1.05] | 2.46 ± 5.42 [0.85] |
By place of servicem | |||
Inpatient stay | 0.08 ± 1.17 [0.00] | 0.05 ± 0.93 [0.00] | 0.10 ± 1.36 [0.00] |
ED visit | 0.07 ± 0.68 [0.00] | 0.07 ± 0.55 [0.00] | 0.07 ± 0.78 [0.00] |
OP visit | 0.79 ± 2.44 [0.00] | 1.08 ± 2.83 [0.17] | 0.50 ± 1.93 [0.00] |
Long-term care/skilled nursing facilities | 0.02 ± 0.29 [0.00] | 0.00 ± 0.02 [0.00] | 0.03 ± 0.41 [0.00] |
Other place of servicen | 0.88 ± 3.88 [0.00] | 0.91 ± 4.05 [0.00] | 0.85 ± 3.70 [0.00] |
Unknown place of serviceo | 1.17 ± 3.73 [0.00] | 1.44 ± 4.15 [0.00] | 0.90 ± 3.23 [0.00] |
Home/hospice care | 0.36 ± 2.55 [0.00] | 0.44 ± 2.86 [0.00] | 0.28 ± 2.18 [0.00] |
Therapeutic services visitp | 0.32 ± 1.62 [0.00] | 0.46 ± 1.85 [0.00] | 0.18 ± 1.34 [0.00] |
Medical suppliesq | 0.21 ± 1.10 [0.00] | 0.18 ± 1.05 [0.00] | 0.25 ± 1.16 [0.00] |
Durable medical equipment user | 0.08 ± 0.76 [0.00] | 0.10 ± 0.89 [0.00] | 0.06 ± 0.60 [0.00] |
Others | 0.22 ± 1.36 [0.00] | 0.33 ± 1.70 [0.00] | 0.10 ± 0.89 [0.00] |